Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Burger

Showing results (171-180 of 342) with videos related to

Pageof 35
Sort By:
Urologia Internationalis|November 2, 2023
Centralizing Penile Cancer Care in Germany and Austria: Just a Dream or a Fast-Approaching Reality? Results of a Survey Study among Urological Department Chairs and Modeling of Real Treatment Numbers of Penile Cancer PatientsAbdulbaki Yakac, Steffen Lebentrau, Lukas Lusuardi, et al.
Virchows Archiv : an International Journal of Pathology|August 13, 2016
ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC)Johannes Breyer, Ralph M Wirtz, Mark Laible, et al.
BJU International|August 19, 2018
FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancerJohannes Breyer, Ralph M Wirtz, Philipp Erben, et al.
Oncotarget|October 6, 2017
Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsiesJohannes Breyer, Ralph Markus Wirtz, Wolfgang Otto, et al.
Clinical Genitourinary Cancer|March 12, 2018
High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder CarcinomaJohannes Breyer, Ralph M Wirtz, Philipp Erben, et al.
World Journal of Urology|June 25, 2016
The German linguistic validation of the Ureteral Stent Symptoms Questionnaire (USSQ)Dominik Abt, Kristina Dötzer, Patrick Honek, et al.
Cancers|May 25, 2024
Long-Term Follow-Up of Peritoneal Interposition Flap in Symptomatic Lymphocele Reduction following Robot-Assisted Radical Prostatectomy: Insights from the PIANOFORTE TrialChristopher Goßler, Matthias May, Steffen Weikert, et al.
Oncology Letters|January 2, 2016
Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancerCédric Poyet, Thomas Hermanns, Qing Zhong, et al.
Urologic Oncology|May 8, 2019
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation studyGeorg C Hutterer, Florian Posch, Lorenz Buser, et al.
World Journal of Urology|January 8, 2024
The landscape of penile cancer research in Germany and Austria: a survey among professors in academic centers holding chair positions and results of a literature searchSemih Sarcan, Ingmar Wolff, Lukas Lusuardi, et al.
Pageof 35

Showing results (171-180 of 342) with videos related to

Sort By:
Pageof 35
Urologia Internationalis|November 2, 2023
Centralizing Penile Cancer Care in Germany and Austria: Just a Dream or a Fast-Approaching Reality? Results of a Survey Study among Urological Department Chairs and Modeling of Real Treatment Numbers of Penile Cancer PatientsAbdulbaki Yakac, Steffen Lebentrau, Lukas Lusuardi, et al.
Virchows Archiv : an International Journal of Pathology|August 13, 2016
ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC)Johannes Breyer, Ralph M Wirtz, Mark Laible, et al.
BJU International|August 19, 2018
FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancerJohannes Breyer, Ralph M Wirtz, Philipp Erben, et al.
Oncotarget|October 6, 2017
Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsiesJohannes Breyer, Ralph Markus Wirtz, Wolfgang Otto, et al.
Clinical Genitourinary Cancer|March 12, 2018
High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder CarcinomaJohannes Breyer, Ralph M Wirtz, Philipp Erben, et al.
World Journal of Urology|June 25, 2016
The German linguistic validation of the Ureteral Stent Symptoms Questionnaire (USSQ)Dominik Abt, Kristina Dötzer, Patrick Honek, et al.
Cancers|May 25, 2024
Long-Term Follow-Up of Peritoneal Interposition Flap in Symptomatic Lymphocele Reduction following Robot-Assisted Radical Prostatectomy: Insights from the PIANOFORTE TrialChristopher Goßler, Matthias May, Steffen Weikert, et al.
Oncology Letters|January 2, 2016
Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancerCédric Poyet, Thomas Hermanns, Qing Zhong, et al.
Urologic Oncology|May 8, 2019
BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation studyGeorg C Hutterer, Florian Posch, Lorenz Buser, et al.
World Journal of Urology|January 8, 2024
The landscape of penile cancer research in Germany and Austria: a survey among professors in academic centers holding chair positions and results of a literature searchSemih Sarcan, Ingmar Wolff, Lukas Lusuardi, et al.
Pageof 35